Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

Rhea-AI Summary

Tarsus Pharmaceuticals (NASDAQ: TARS) has scheduled its second quarter 2025 financial results announcement and corporate update for Wednesday, August 6, 2025. The company will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET. Following the live presentation, a recorded version will be available on the company's website and remain accessible for approximately 90 days.

News Market Reaction

-2.95%

1 alert

-2.95% News Effect

On the day this news was published, TARS declined 2.95%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, August 6, 2025, to report its second quarter 2025 financial results and provide a corporate update.

Participants may access the webcast here. A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for approximately 90 days.

About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY^® (lotilaner ophthalmic solution) 0.25% is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease.

Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com

Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com

FAQ

When will Tarsus Pharmaceuticals (TARS) report Q2 2025 earnings?

Tarsus Pharmaceuticals will report its Q2 2025 earnings on Wednesday, August 6, 2025 at 1:30 p.m. PT / 4:30 p.m. ET.

How can investors access the Tarsus Pharmaceuticals Q2 2025 earnings call?

Investors can access the earnings call through a live webcast available on the company's website.

How long will the Tarsus Pharmaceuticals Q2 2025 earnings call recording be available?

The recorded version of the earnings call will be archived on the company's website for approximately 90 days.

What will be discussed during the Tarsus Pharmaceuticals August 6 webcast?

The webcast will cover Tarsus Pharmaceuticals' Q2 2025 financial results and provide a corporate update.